Form 4: Amneal Pharmaceuticals Executive Vice President Tasos Konidaris Reports Stock Transactions
SEC Form 4 Filing
Executive Vice President and CFO of Amneal Pharmaceuticals, Tasos Konidaris, reports the vesting of restricted stock units and subsequent tax withholding.
Summary
- On March 1, 2025, Tasos Konidaris, Executive Vice President & CFO of Amneal Pharmaceuticals, had restricted stock units vest, resulting in the acquisition of 36,197 shares of Class A Common Stock.
- A portion of these shares (13,494) were withheld to cover tax obligations at a price of $8.67 per share.
- Following these transactions, Konidaris directly owns 550,019 shares of Class A Common Stock.
- The restricted stock units were granted on March 1, 2021, and vest in four equal annual installments.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of stock transactions related to executive compensation. It doesn't inherently indicate positive or negative sentiment about the company's performance.
Industry Context
This filing is a routine disclosure of insider transactions, common for executives receiving stock-based compensation. It provides transparency into the executive's holdings and recent transactions in the company's stock.
Stakeholder Impact
- The transaction has a minor impact on shareholders as it reflects the standard compensation practices for executives.
- Employees may view this as a standard part of executive compensation.
Key Dates
| Date | Description |
|---|---|
| 03/01/2021 | Reporting person was granted 144,788 restricted stock units, vesting in four equal installments beginning on the first anniversary of the grant date. |
| 03/01/2025 | Restricted stock units vested, and shares were withheld for tax obligations. |
| 03/04/2025 | Date of the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.